Plasma Protease C1-inhibitor Treatment Market Poised to Grow...

ha aggiunto un file Business

2024-01-30 10:28:17 - Translate

Plasma Protease C1-inhibitor Treatment Market Poised to Grow Substantially Due to Rising Prevalence of Hereditary Angioedema

The global plasma protease C1-inhibitor treatment market is estimated to be valued at US$ 6257.99 Bn in 2024 and is expected to exhibit a CAGR of 6.7% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. SWOT Analysis Strength: Plasma protease C1-inhibitor treatment offers a safe and effective treatment for...

0 Commenti 0 condivisioni 434 Views 0 Anteprima